Vertex Pharmaceuticals News - VRTX

Company Name	Stock Ticker Symbol	Market	Type
Vertex Pharmaceuticals Inc	VRTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-3.99	-1.15%	343.845	12:32:47

Open Price	Low Price	High Price	Close Price	Prev Close
345.28	341.85	347.79		347.83

more quote information »

Recent News

Date	Time	Source	Heading
10/03/2023	8:50	IHNW	FeaturedCannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
10/03/2023	11:11	EDGAR2	Form 144 - Report of proposed sale of securities
10/02/2023	12:34	EDGAR2	Form 144 - Report of proposed sale of securities
9/21/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	09:55	EDGAR2	Form 144 - Report of proposed sale of securities
9/15/2023	09:39	DJN	Vertex Pharmaceuticals Gets European Regulators' Nod for..
9/15/2023	08:52	BW	Vertex Receives CHMP Positive Opinion for KAFTRIO®..
9/14/2023	09:15	BW	Vertex Researchers Awarded 2024 Breakthrough Prize in Life..
9/07/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	16:23	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/05/2023	15:03	EDGAR2	Form 144 - Report of proposed sale of securities
8/30/2023	16:01	BW	Vertex to Participate in the Morgan Stanley 21st Annual..
8/29/2023	09:00	BW	Vertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief..
8/25/2023	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	12:37	EDGAR2	Form 144 - Report of proposed sale of securities
8/14/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/11/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/11/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/10/2023	13:50	EDGAR2	Form 144 - Report of proposed sale of securities
8/10/2023	13:07	EDGAR2	Form 144 - Report of proposed sale of securities
8/10/2023	10:47	EDGAR2	Form 144 - Report of proposed sale of securities
8/09/2023	12:04	EDGAR2	Form 144 - Report of proposed sale of securities
8/09/2023	10:14	EDGAR2	Form 144 - Report of proposed sale of securities
8/03/2023	08:00	BW	Vertex Announces Publication of VX-548 Positive Phase 2,..
8/02/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/2023	16:48	DJN	Vertex Pharmaceuticals 2Q Profit Up On Higher Cystic..
8/01/2023	16:03	EDGAR2	Form 8-K - Current report
8/01/2023	16:01	BW	Vertex Reports Second Quarter 2023 Financial Results
7/18/2023	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/18/2023	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/18/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/17/2023	13:40	EDGAR2	Form 144 - Report of proposed sale of securities
7/17/2023	12:26	EDGAR2	Form 144 - Report of proposed sale of securities
7/05/2023	03:00	BW	European Commission Approves ORKAMBI® (lumacaftor/ivacaftor)..
6/30/2023	08:01	BW	Vertex to Announce Second Quarter 2023 Financial Results on..
6/26/2023	07:30	BW	Vertex and Lonza to Build Dedicated Manufacturing Facility..
6/23/2023	18:55	BW	Vertex Presents Positive VX-880 Results From Ongoing Phase..
6/09/2023	11:00	BW	Vertex Presents Data Demonstrating Significant Benefits of..
6/09/2023	03:01	BW	Positive Results From Pivotal Trials of exa-cel for..
6/08/2023	19:23	BW	FDA Accepts Biologics License Applications for exagamglogene..
5/30/2023	08:01	BW	Vertex to Participate in the Goldman Sachs 44th Annual..
5/05/2023	12:05	DJN	Vertex Pharmaceuticals On Pace for Record High Close -- Data..
5/03/2023	17:07	BW	Vertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor)..
5/01/2023	16:48	DJN	Vertex Pharmaceuticals 1Q Net Down On Higher Costs
5/01/2023	16:01	BW	Vertex Reports First Quarter 2023 Financial Results
4/27/2023	02:00	BW	Vertex Receives CHMP Positive Opinion for ORKAMBI®..
4/26/2023	14:33	DJN	Vertex: FDA OKs Trikafta for Some Children Ages 2 Through 5..
4/26/2023	13:37	BW	Vertex Announces U.S. FDA Approval for TRIKAFTA®..
4/25/2023	08:01	BW	Vertex to Present at the Bank of America Securities 2023..